Navigation Links
75 Percent of Hospital IT Leaders View Interoperability Between Vendor Systems as Critical to Operational Effectiveness in Healthcare Settings
Date:2/23/2011

MOUNTAIN VIEW, Calif., Feb. 23, 2011 /PRNewswire/ -- Omnicell, Inc., (Nasdaq: OMCL) a leading provider of medication management systems to healthcare facilities, today announced the results of a survey conducted at HIMSS 2011. 100 healthcare executives were polled to identify trends in requirements for vendor interoperability and factors motivating hospital IT purchasing decisions. The survey found that the majority of hospitals recognize the critical role interoperability plays in improving patient care.

The survey results identified the following trends as top concerns among hospital IT leaders attending HIMSS:

  • The interoperability of multiple vendor systems within a hospital's IT infrastructure is deemed critical to operational effectiveness by 75 percent of hospital IT leadership.
  • 38 percent of hospitals are changing the way they purchase, distribute and manage medication and supplies due to financial pressures.
  • When considering system maintenance, costs and patient care, 66 percent identified patient centered care as the most important criteria when investing in IT resources to improve systems-based interoperability within a facility.

"It is exciting to see that over 75 percent of hospital IT leadership identified that interoperability in a hospital's IT infrastructure is critical to hospital operational effectiveness," said Marga Ortigas-Wedekind, Omnicell vice president, global marketing and product development. "The interoperability of Omnicell solutions is demonstrated daily in over 1600 hospitals nationwide. These survey results reinforce Omnicell's ability to address hospital IT leadership concerns in a meaningful way."

Omnicell announced they are demonstrating interoperable standards-based technology solutions with their automated dispensing cabinets for medication management at the HIMSS11 Interoperability Showcase. The Showcase is part of the 2011 Annual HIMSS Conference and Exhibition and is held in collaboration with Integrating the Healthcare Enterprise (IHE). The Showcase is located in Hall E of the Orange County Convention Center in Orlando, Florida from February 20-24, 2011.

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems to enable healthcare facilities to increase operational efficiency, enhance patient safety and allow clinicians to spend more time with their patients.

Founded in 1992, Omnicell's medication-use solutions include complete automation systems for the central pharmacy, anesthesia workstations for the operating room, dispensing cabinet systems for nursing units, and safe, secure medication transportation and verification systems to the patient bedside. From a medication's arrival at the receiving dock to its dosing to the patient, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.  

Omnicell supply product lines provide a healthcare institution with comprehensive supply chain solutions that result in fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab, and operating room.

OMCL - G


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
2. Hill-Rom Reports 77 Percent Growth in First Quarter Earnings Per Share
3. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
4. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
5. Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease
6. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
7. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
8. Sales of Revlimid and the Launch of Several Premium-Priced Emerging Therapies Will Drive Robust 7.2 Percent Annual Growth in the Multiple Myeloma Drug Market
9. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
10. Volcano Reports 35 Percent Increase in Third Quarter Revenues; Records $9.6 Million Improvement in Year-Over-Year GAAP Profitability
11. Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... SAN DIEGO , Oct. 12, 2017 ... has recognized the company with their  2017 New Product Innovation ... is based on extensive primary and secondary medical device market ... AVACEN Medical, through its first-to-market OTC, drug-free pain relief product, ... a unique approach to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology:
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
Breaking Medicine News(10 mins):